Jaquelin Anne Bousie

Dr. Jaquelin Anne Bousie

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Journal of Science and Medicine in Sport
Verified
Journal Article
Closed access
JBJaquelin Anne Bousie
Jaquelin Anne Bousie
PBPeter Blanch
Peter Blanch
TMThomas G. McPoil
Thomas G. McPoil
BVBill Vicenzino
Bill Vicenzino

1 July 2018 in Journal of Science and Medicine in Sport
Verified
Journal Article
Closed access
JBJaquelin Anne Bousie
Jaquelin Anne Bousie
PBPeter Blanch
Peter Blanch
TMThomas G. McPoil
Thomas G. McPoil
BVBill Vicenzino
Bill Vicenzino

NFNicole Freene
Nicole Freene
KPKatie Porra
Katie Porra
JBJaquelin Anne Bousie
Jaquelin Anne Bousie
Mark NauntonMark Naunton
Mark Naunton
NBNick Ball
Nick Ball
AGAnn B. Gates
Ann B. Gates
The promotion of physical activity (PA) by health professionals is a key strategy to increase PA levels in the population. In this study, we investigated PA promotion, preparedness, and knowledge among university nursing and allied health students and staff, as well as PA resource usage within curricula, before and after an educational intervention. Students and staff from 13 health disciplines at one Australian university were invited to complete an online survey, and a curriculum audits were conducted before and after PA teaching resources were promoted by academic PA champions (n = 14). A total of 299 students and 43 staff responded to the survey pre-intervention, and 363 and 32 responded to the post-intervention, respectively. PA promotion role perception (≥93%) and confidence to provide general PA advice (≥70%) were high throughout the study. Knowledge of PA guidelines was poor (3–10%). Students of physiotherapy, sport and exercise science, as well as more active students, were more likely to be aware of the PA guidelines (p < 0.05). Over 12 months, PA promotion preparedness and knowledge did not change significantly, nor was there a change in the amount of PA content delivered, despite a significant increase in the use of the teaching resources across a number of disciplines (p = 0.007). Future research should be carried out to investigate the implementation of the resources over time and to develop additional strategies for PA promotion and education scaffolded across curricula.

26 September 2022 in Exploratory Research in Clinical and Social Pharmacy
Verified
Journal Article
Open access
Laura Jane MackenzieLaura Jane Mackenzie
Laura Jane Mackenzie
MBMary-Jessimine A. Bushell
Mary-Jessimine A. Bushell
PNPhillip Newman
Phillip Newman
JBJaquelin Anne Bousie
Jaquelin Anne Bousie
Background: Shoulder injury related to vaccine administration (SIRVA) has been recognised as the compensable term for any shoulder injury that may result from an improper vaccination technique since 2017, however, its incidence and impact remain poorly understood. Objectives: To examine knowledge of SIRVA through reported cases, determine SIRVA incidence related to COVID-19 vaccinations, and investigate recovery rates. Methods: Six pharmacovigilance agencies in the United States of America (USA), Canada, United Kingdom, European Union, Australia, and New Zealand were systematically search to identify all reported cases of SIRVA between January 2017 to July 2021. Primary outcome measures were SIRVA case reports. Secondary outcome measures included recovery status as well as vaccine received, age, and sex. SIRVA-related outcome measures were retrieved between July 18th and July 22nd 2021, with UK data received via personal correspondence. Results: Retrospective analysis yielded 505 SIRVA cases since 2017, with 330 (65%) of cases reported from January to July 2021. Sub-analysis, using COVID-19 data of 189 SIRVA cases from 891,906,986 vaccinations, estimated incidence to be 2 per 10 million. 32 cases (7%) had recovered from symptoms at the time of reporting, with 311 (62%) reported as 'not recovered', and 162 cases (32%) 'unknown'. Females represented 75% of reported cases. Conclusion: SIRVA case report numbers and incidence from COVID-19 data, compared with prior evidence, raises questions around health practitioner knowledge and reporting accuracy of SIRVA. Recovery rates are poorly understood. A global consensus definition of SIRVA and more transparent and routine reporting is required. The disproportionate representation of females is of concern with no known reasons for this disparity. Further research is needed on SIRVA knowledge in healthcare practitioners, reporting rates, incidence, management, and long-term outcomes for those impacted. Pharmacist vaccinators should be aware of their role in preventing SIRVA and be active in its detection.

23 November 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
Laura Jane MackenzieLaura Jane Mackenzie
Laura Jane Mackenzie
JBJaquelin Anne Bousie
Jaquelin Anne Bousie
PNPhil Newman
Phil Newman
JWJanique Waghorn
Janique Waghorn
JCJohn Edward Cunningham
John Edward Cunningham
MBMary-Jessimine Bushell
Mary-Jessimine Bushell
Background: Vaccine pharmacovigilance is at the forefront of the public eye. Shoulder Injuries Related to Vaccine Administration (SIRVA) is a poorly understood Adverse Event Following Immunisation, with iatrogenic origins. Criteria for medicolegal diagnosis of SIRVA is conflicting, current literature and educational materials are lacking, and healthcare practitioner knowledge of the condition is unknown. Methods: A cross-sectional, convenience sampled survey, utilising a validated online questionnaire assessed practitioner knowledge of SIRVA, safe injecting, and upper limb anatomy, and preferred definition for SIRVA. Results: Mean scores were moderate for safe injecting knowledge (69%), and poor for knowledge of anatomy (42%) and SIRVA (55%). Non-immunising healthcare practitioners scored significantly (p = 0.01, and < 0.05, respectively) higher than immunising practitioners for anatomy (2.213 ± 1.52 vs. 3.12 ± 1.50), and safe injecting knowledge (6.70 ± 1.34 vs. 7.14 ± 1.27). Only 52% of authorised vaccinators accurately selected a 40 × 20 mm area recommended for safe injecting. Majority (91.7%) of respondents thought nerve injuries should be included in the diagnostic criteria for SIRVA. Discussion and conclusions: Greater education and awareness of SIRVA is needed in all healthcare disciplines. Consensus regarding SIRVA definition is paramount for accurate reporting and improved future understanding of all aspects of SIRVA.

21 October 2022 in Gait & Posture
Verified
Journal Article
Closed access
JHJayden Hunter
Jayden Hunter
WSWayne Spratford
Wayne Spratford
AFAngie Fearon
Angie Fearon
JBJaquelin Anne Bousie
Jaquelin Anne Bousie